Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,732 | -9,237 | -6,439 | -2,612 | -6,826 |
| Accounts payable and accrued liabilities | 154 | 190 | -34 | -106 | 271 |
| Other Working Capital | 1,165 | 1,742 | 1,358 | 366 | 908 |
| Other Operating Activity | 731 | 471 | 472 | 318 | 210 |
| Operating Cash Flow | $-9,683 | $-6,834 | $-4,643 | $-2,034 | $-5,437 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,699 | 6,699 | 6,699 | 6,699 | N/A |
| Other Financing Activity | -317 | -249 | -249 | 0 | 0 |
| Financing Cash Flow | $6,382 | $6,450 | $6,450 | $6,699 | $N/A |
| Beginning Cash Position | 14,549 | 14,549 | 14,549 | 14,549 | 19,986 |
| End Cash Position | 11,247 | 14,165 | 16,355 | 19,214 | 14,549 |
| Net Cash Flow | $-3,301 | $-384 | $1,807 | $4,665 | $-5,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,683 | -6,834 | -4,643 | -2,034 | -5,437 |
| Free Cash Flow | -9,683 | -6,834 | -4,643 | -2,034 | -5,437 |